普雷西根生物 PGEN
$4.47 +$0.25 (+5.92%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $4.44 -0.67%
开盘$4.32
昨收$4.22
当日区间$4.03 – $4.48
成交量9.24M
市值$1.60B
市盈率（TTM）40.6
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$54.98M+6,322.7% YoY
营业利润$22.64M+181.3% YoY
净利润$20.07M+175.3% YoY
摊薄每股收益$0.05+155.6% YoY
自由现金流-$18.20M+8.7% YoY
经营现金流-$17.81M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率90.7%
营业利润率-46.1%
净利率-392.8%
净资产收益率-9,907.5%
资产收益率-247.4%
投入资本回报率-597.7%
流动比率4.58
负债/资产比率74.4%
现金及投资$38.21M
总负债$97.29M
净现金（净负债）-$59.08M
营收构成
2026/Q2 季度
按业务线
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $54.98M | $23.25M | $9.68M | $4.57M | $2.92M |
| 营业总收入 | $54.98M | $23.25M | $9.68M | $4.57M | $2.92M |
| 营业成本 | $2.81M | $2.56M | $4.82M | $1.60M | $1.04M |
| 毛利润 | $52.17M | $20.69M | $4.86M | $2.97M | $1.89M |
| 营业费用 | $29.53M | $26.69M | $111.46M | $24.64M | $36.37M |
| 销售及管理费用 | $22.25M | $21.05M | $70.13M | $17.65M | $23.99M |
| 研发费用 | $7.28M | $5.64M | $41.33M | $6.99M | $12.38M |
| 营业利润 | $22.64M | -$5.99M | -$106.60M | -$21.67M | -$34.48M |
| 非经营性利息净收入（支出） | -$2.59M | -$2.23M | -$652,000.00 | -$1.90M | -$368,000.00 |
| 非经营性利息收入 | $366,000.00 | $683,000.00 | $3.22M | $1.07M | $534,000.00 |
| 非经营性利息支出 | $2.95M | $2.91M | $3.87M | $2.96M | $902,000.00 |
| 其他收入（支出） | $16,000.00 | $290,000.00 | -$143.39M | $60,000.00 | -$111.50M |
| 特殊收益（费用） | $0.00 | – | -$3.91M | $0.00 | $0.00 |
| -减：资本性资产减值 | $0.00 | – | $3.91M | $0.00 | $0.00 |
| 其他非经营性收入（支出） | $16,000.00 | $290,000.00 | $43,000.00 | $60,000.00 | $7,000.00 |
| 税前利润 | $20.07M | -$7.93M | -$250.64M | -$23.50M | -$146.34M |
| 税费 | $0.00 | $0.00 | $3,000.00 | $0.00 | $0.00 |
| 净利润 | $20.07M | -$7.93M | -$250.64M | -$23.50M | -$146.34M |
| 持续经营利润 | $20.07M | -$7.93M | -$250.64M | -$23.50M | -$146.34M |
| 归属母公司净利润 | $20.07M | -$7.93M | -$250.64M | -$23.50M | -$146.34M |
| 归属普通股股东净利润 | $20.07M | -$7.93M | -$429.64M | -$23.50M | -$325.34M |
| 基本每股收益 | $0.06 | -$0.02 | -$1.37 | -$0.01 | -$1.06 |
| 摊薄每股收益 | $0.05 | -$0.02 | -$1.37 | -$0.01 | -$1.06 |
| 证券出售收益 | – | – | -$139.52M | $0.00 | -$111.50M |
| 优先股股息 | – | – | $179.00M | $0.00 | $179.00M |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $170.30M | $138.63M | $155.51M | $155.51M | $171.26M |
| 流动资产合计 | $134.38M | $101.67M | $115.24M | $115.24M | $129.60M |
| 现金及现金等价物与短期投资 | $38.21M | $56.25M | $97.86M | $97.86M | $121.14M |
| -现金及现金等价物 | $16.33M | $7.48M | $30.23M | $30.23M | $14.32M |
| -短期投资 | $21.88M | $48.77M | $67.62M | $67.62M | $106.81M |
| 应收款 | $72.04M | $26.71M | $4.36M | $4.36M | $1.10M |
| -应收账款 | $71.87M | $26.40M | $3.92M | $3.92M | $580,000.00 |
| -其他应收款 | $178,000.00 | $302,000.00 | $446,000.00 | $446,000.00 | $520,000.00 |
| 存货 | $20.25M | $14.73M | $9.58M | $9.58M | $3.06M |
| 其他流动资产 | $3.89M | $4.00M | $3.43M | $3.43M | $4.30M |
| 非流动资产合计 | $35.91M | $36.96M | $40.27M | $40.27M | $41.67M |
| 固定资产净值 | $16.87M | $17.52M | $18.36M | $18.36M | $19.60M |
| -固定资产原值 | $42.25M | $42.12M | $42.19M | $42.19M | $42.60M |
| -累计折旧 | -$25.38M | -$24.60M | -$23.82M | -$23.82M | -$23.01M |
| 投资及预付款 | $490,000.00 | $489,000.00 | $2.51M | $2.51M | $2.51M |
| -可供出售证券 | $490,000.00 | $489,000.00 | $2.51M | $2.51M | $2.51M |
| 商誉及其他无形资产 | $17.78M | $18.10M | $18.41M | $18.41M | $18.73M |
| -商誉 | $15.23M | $15.23M | $15.23M | $15.23M | $15.23M |
| -其他无形资产 | $2.55M | $2.86M | $3.18M | $3.18M | $3.50M |
| 其他非流动资产 | $771,000.00 | $852,000.00 | $982,000.00 | $982,000.00 | $832,000.00 |
| 负债合计 | $126.72M | $118.39M | $134.59M | $134.59M | $129.40M |
| 流动负债合计 | $29.35M | $21.10M | $37.31M | $37.31M | $32.07M |
| 应付款 | $5.30M | $2.59M | $11.99M | $11.99M | $6.26M |
| -应付账款 | $5.30M | $2.59M | $11.99M | $11.99M | $6.26M |
| 一年内应计费用 | $16.21M | $12.48M | $13.47M | $13.47M | $14.04M |
| 短期债务及融资租赁负债 | $1.06M | $1.07M | $1.14M | $1.14M | $1.12M |
| -一年内到期融资租赁负债 | $1.06M | $1.07M | $1.14M | $1.14M | $1.12M |
| 一年内递延负债 | $284,000.00 | $410,000.00 | $517,000.00 | $517,000.00 | $480,000.00 |
| 非流动负债合计 | $97.37M | $97.29M | $97.29M | $97.29M | $97.33M |
| 长期债务及融资租赁负债 | $97.29M | $97.18M | $97.15M | $97.15M | $97.07M |
| -长期债务 | $93.88M | $93.52M | $93.17M | $93.17M | $92.89M |
| -长期融资租赁负债 | $3.41M | $3.66M | $3.98M | $3.98M | $4.18M |
| 其他非流动负债 | $77,000.00 | $106,000.00 | $134,000.00 | $134,000.00 | $163,000.00 |
| 股东权益合计 | $43.58M | $20.24M | $20.91M | $20.91M | $41.87M |
| 股东权益 | $43.58M | $20.24M | $20.91M | $20.91M | $41.87M |
| 股本 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -普通股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $2.37B | $2.37B | $2.36B | $2.36B | $2.36B |
| 留存收益 | -$2.33B | -$2.35B | -$2.34B | -$2.34B | -$2.32B |
| 不影响留存收益的损益 | -$29,000.00 | -$17,000.00 | $7,000.00 | $7,000.00 | $24,000.00 |
| 衍生产品负债 | – | – | $0.00 | $0.00 | $0.00 |
| 一年以上递延负债 | – | – | $0.00 | $0.00 | $95,000.00 |
| 可转换优先证券 | – | – | $0.00 | $0.00 | $0.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$17.81M | -$43.83M | -$87.83M | -$23.46M | -$29.07M |
| 持续经营经营活动现金流净额 | -$17.81M | -$43.83M | -$87.83M | -$23.46M | -$29.07M |
| 持续经营净利润 | $20.07M | -$7.93M | -$250.64M | -$23.50M | -$146.34M |
| 折旧、折耗与摊销 | $1.10M | $1.10M | $3.20M | $1.14M | $803,000.00 |
| 其他非现金项目 | $361,000.00 | -$1.61M | $146,000.00 | -$453,000.00 | $72,000.00 |
| 营运资金变动 | -$42.71M | -$38.03M | $7.36M | -$2.09M | $828,000.00 |
| -应收款变动 | -$45.34M | -$22.34M | -$3.20M | -$3.26M | -$532,000.00 |
| -存货变动 | -$5.79M | -$4.88M | -$9.21M | -$6.26M | -$2.95M |
| -预付资产变动 | $109,000.00 | -$562,000.00 | -$93,000.00 | $869,000.00 | -$1.87M |
| -应付账款及应计费用变动 | $6.47M | -$7.89M | $15.64M | $6.80M | $2.78M |
| -其他流动资产变动 | $74,000.00 | $126,000.00 | -$556,000.00 | -$174,000.00 | -$167,000.00 |
| -其他流动负债变动 | -$61,000.00 | -$103,000.00 | $125,000.00 | -$33,000.00 | $257,000.00 |
| -其他营运资金变动 | $1.82M | -$2.38M | $4.66M | -$25,000.00 | $3.31M |
| 投资活动现金流净额 | $26.69M | $20.97M | -$1.54M | $39.87M | -$63.39M |
| 持续经营投资活动现金流净额 | $26.69M | $20.97M | -$1.54M | $39.87M | -$63.39M |
| 固定资产购置及出售净额 | -$392,000.00 | -$258,000.00 | -$2.00M | -$18,000.00 | -$389,000.00 |
| 投资购置及出售净额 | $27.08M | $21.23M | $460,000.00 | $39.88M | -$63.00M |
| 筹资活动现金流 | -$33,000.00 | $109,000.00 | $90.05M | -$514,000.00 | $93.01M |
| 持续经营筹资活动现金流净额 | -$33,000.00 | $109,000.00 | $90.05M | -$514,000.00 | $93.01M |
| 普通股发行净额 | $0.00 | $0.00 | -$1.66M | $0.00 | -$1.30M |
| 股票期权行使所得 | $1.32M | $255,000.00 | $1.20M | $140,000.00 | $839,000.00 |
| 其他筹资费用净额 | -$1.35M | -$146,000.00 | -$1.78M | $537,000.00 | $0.00 |
| 期末现金余额 | $16.33M | $7.48M | $30.23M | $30.23M | $14.32M |
| 现金净变动 | $8.85M | -$22.75M | $682,000.00 | $15.89M | $552,000.00 |
| 期初现金余额 | $7.48M | $30.23M | $29.52M | $14.32M | $13.76M |
| 汇率变动影响 | $1,000.00 | -$3,000.00 | $35,000.00 | $20,000.00 | $10,000.00 |
| 自由现金流 | -$18.20M | -$44.09M | -$89.83M | -$23.48M | -$29.46M |
| 持续经营损益 | – | – | $139.54M | $0.00 | $111.50M |
| 递延税款 | – | – | $0.00 | $0.00 | – |
| 债务发行及偿还净额 | – | – | $92.82M | -$654,000.00 | – |
| 优先股发行净额 | – | – | -$537,000.00 | – | – |
暂无评论——快来第一个聊聊 PGEN。